Skip to main navigation Skip to search Skip to main content

Use of thiazolidinediones and glucagon-like peptide-1 receptor agonists and the risk of non-alcoholic fatty liver disease

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)128-128
Number of pages1
JournalPharmacoepidemiology and Drug Safety
Volume29
Publication statusPublished - Oct 2020

Cite this